An amiloride derivative is active against the F1Fo-ATP synthase and cytochrome bd oxidase of Mycobacterium tuberculosis

Overview of attention for article published in Communications Biology, February 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 11 X posts from 10 X users, with an upper bound of 16,137 followers.

RT @CommsBio: Derivatives of FDA-approved amiloride eliminate drug-resistant M. tuberculosis in vitro by interfering with bacterial energy…

Just last month, @cooklabuoonz used derivatives of the FDA-approved drug, amiloride, to eliminate drug-resistant M. tuberculosis in vitro. 💊 https://t.co/sfE7F7TKWh [Credit: Unsplash] https://t.co/ykcYTzIr8h

Latest publication with a contribution from Otago Biochemistry. An amiloride derivative is active against the F 1 F o-ATP synthase and cytochrome bd oxidase of Mycobacterium tuber… https://t.co/SGCzyRn3Uo

RT @ThomasMeierLab: Check this one out if you are interested in new compounds as potential drugs against respiratory chain complexes and AT…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.